Use of substances of animal origin in pharmaceutics and compliance with the TSE-risk guideline - A market survey

Biologicals

Volumn 33, Issue 1, 2005, Pages 1-7

  Berger, Christoph N ^a   Le Donne, Patrizia ^a   Windemann, Helena ^a  

^a Swissmedic   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; APROTININ; CATALASE; DEOXYRIBONUCLEASE; EXCIPIENT; GELATIN; HEPARIN; INSULIN; LACTOSE; LIPID; POLYSORBATE; TALLOW DERIVATIVE; UNCLASSIFIED DRUG; VETERINARY DRUG;

DISEASE TRANSMISSION; DOCUMENTATION; DRUG MANUFACTURE; DRUG SURVEILLANCE PROGRAM; GEOGRAPHY; HUMAN; INFECTION RISK; NONHUMAN; PRACTICE GUIDELINE; PRION DISEASE; PRIORITY JOURNAL; REVIEW;

ANIMALIA;

EID: 13844267001     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biologicals.2004.10.002     Document Type: Article

References (24)

1. Swissmedic TSE guideline to the ordinance http://www.swissmedic.ch/files/ pdf/Anleitung_TSE.pdf 2001
2. The European Directorate for the Quality of Medicines Minimising the risk of transmitting animal spongiform encephalopathy agents via medicinal products European Pharmacopoeia 2002 General chapter 5.2.8 http://www.pheur.org/medias/ download/50208E.pdf
3. J. Collinge, K.C. Sidle, J. Meads, J. Ironside, and A.F. Hill Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD Nature 383 1996 685 690
4. R.G. Will, J.W. Ironside, M. Zeidler, S.N. Cousens, K. Estibeiro, and A. Alperovitch A new variant of Creutzfeldt-Jakob disease in the UK Lancet 347 1996 921 925
5. L'Office International d'Epizooties Bovine spongiform encephalopathy (BSE). Geographical distribution of countries that reported BSE confirmed cases http://www.oie.int/eng/info/en_esb.htm 2003
6. Animal and Plant Health Inspection Service of USA Bovine spongiform encephalopathy (BSE). USDA actions to prevent bovine spongiform encephalopathy http://www.aphis.usda.gov/lpa/issues/bse/bsechron.html 2003
7. Therapeutic Goods Administration of Australia Supplementary requirements for therapeutic goods for minimising the risk of transmitting transmissible spongiform encephalopathies (TSEs) http://www.health.gov.au/tga/docs/pdf/ tsesupp.pdf 2003
8. The World Health Organisation Guidelines on transmissible spongiform encephalopathies in relation to biological and pharmaceutical products 2003 WHO/BCT/QSD/0.3.01
9. Interkantonale Kontrollstelle für Heilmittel der Schweiz. BSE Beschluss. Monatsbericht der IKS;1991;3/91.
10. Interkantonale Kontrollstelle für Heilmittel der Schweiz. TSE Beschluss. Monatsbericht der IKS; 2000;1/01.
11. Swissmedic Formular: Gesuch um Zulassung/Änderung http://www.swissmedic.ch/files/pdf/B3.1.11 2001
12. Swissmedic Formular: Stoffe tierischen und humanen Ursprungs http://www.swissmedic.ch/files/pdf/B3.1.91 2001
13. Interkantonale Kontrollstelle für Heilmittel der Schweiz. Ergänzung zum TSE Beschluss. Monatsbericht der IKS; 2001;1/01.
14. The European Agency for the Evaluation of Medical Products Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via medicinal products 2001 EMEA/410/01 rev1
15. The European Commission Note for guidance on minimizing the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products Official Journal of the European Union C 24/03 2004 6 19
16. D.M. Taylor, S.L. Woodgate, and M.J. Atkinson Inactivation of the bovine spongiform encephalopathy agent by rendering procedures Vet Rec 137 1995 605 610
17. The Scientific Steering Committee of the European Commission Updated opinion on the safety with regard to TSE risks of gelatine derive from ruminant bones or hides http://europa.eu.int/comm/food/fs/sc/ssc/out321_en.pdf 2003
18. The Scientific Steering Committee of the European Commission Final opinion of the Scientific Steering Committee on the geographical risk of bovine spongiform encephalopathy (GBR) http://europa.eu.int/comm/food/fs/sc/ssc/ out113_en.pdf 2000
19. The Scientific Steering Committee of the European Commission Update of the opinion of the Scientific Steering Committee on the geographical risk of bovine spongiform encephalopathy (GBR) http://europa.eu.int/comm/food/fs/sc/ssc/ out291_en.pdf 2001
20. The European Food Safety Agency. The Panel on biological hazards deals with questions on biological hazards relating to food safety and food-borne disease, including food-borne zoonoses and transmissible spongiform encephalopathies, microbiology, food hygiene and associated waste management; 2003. http://www.efsa.eu.int/science/biohaz/catindex_en.html.
21. The European Food Safety Agency. EFSA publishes Geographical BSE-Risk (GBR) assessments for Australia, Canada, Mexico, Norway, South Africa, Sweden and the United States of America; 2004. http://www.efsa.eu.int/science/ tse_assessments/gbr_assessments/573_en.html.
22. The European Agency for the Evaluation of Medical Products Note for Guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products. Amendments to sections 6.2 and 6.3 2004 EMEA/410/01 rev2
23. G. Amexis, J. Ridge, L. Cervenakova, J.C. Enterline, K.M. Chumakov, and D.M. Asher Stability of the prion protein-encoding (PRNP) gene in HeLa cells Biologicals 31 2003 83 86
24. BSE Einheit des Bundes Jahresbericht 2002 http://www.bse-einheit.ch/bse- einheit/Bibliothek/Home/BMedienUPublikationen/AReportBSEEinheit/default_D.asp 2002